申请人:Synta Pharmaceuticals Corp.
公开号:US20130317032A1
公开(公告)日:2013-11-28
The invention relates to compounds of structural formula (I):
or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof, wherein R′
1
, X, X′, L and Y are defined herein. These compounds are useful as immunosuppressive agents and for treating and preventing inflammatory conditions, allergic disorders, and immune disorders.
本发明涉及结构式(I)的化合物:或其药学上可接受的盐,溶剂化合物,笼合物或前药,其中R′1,X,X′,L和Y在此定义。这些化合物可用作免疫抑制剂,并用于治疗和预防炎症疾病,过敏性疾病和免疫性疾病。